INNV Market Analysis
Wall Street coverage
third-party contextWall Street coverage
$10.50median target· current $10.85 (-3.2%)3 analysts
Via 3rd party. Not a recommendation or advice by The Balanced Investor Club. See disclaimer.
News & Sentiment
50 articles · sorted by datePage 1 of 3 · 50 total
Via 3rd party. Not a recommendation or advice by The Balanced Investor Club. See disclaimer.
Fundamentals
Updated daily after market closeP/E ratio—Forward 13.66
EPS (TTM)$-0.02-87.8% YoY
Profit margin-0.3%HEALTHCARE
Market cap$1.48BSmall cap
Valuation
- Forward P/E
- 13.66
- PEG ratio
- 0.00
- P/B
- 6.33
- P/S (TTM)
- 1.50
- EV/EBITDA
- 55.99
Profitability & growth
- ROE (TTM)
- -0.3%
- Operating margin
- 5.0%
- Revenue growth YoY
- 18.3%
- Dividend yield
- —
- Beta
- 0.39
Last earnings
Sep 8, 2026 · Estimate $0.09 · Reported $0.06
Analyst estimate. Actual results often differ.
Ratios are point-in-time. Historical metrics — no guarantees about what comes next.
About InnovAge Holding Corp
Company profileInnovAge Holding Corp. The company is headquartered in Denver, Colorado.
Classification
- Sector
- Healthcare
- Industry
- Medical Care Facilities
- Exchange
- NASDAQ
- Country
- USA
- Currency
- USD
Company profile
- HQ
- 8950 E. LOWRY BOULEVARD, DENVER, CO
- Fiscal year end
- June
- Latest quarter
- Jun 30, 2026
Market cap$1.48B
Shares outstanding$136.5M
52W high$12.64
52W low$3.94
We're educators, not advisors. We don't make buy or sell recommendations under any circumstance. All content is for educational purposes. Past performance doesn't guarantee future results. Your decisions are your own. Disclaimer
Balanced Agent